Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP871793.RAIk9I_72ZjG1xoy2GxS6Rz5mbHYLp6yk9tZT3qYwTUaM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP871793.RAIk9I_72ZjG1xoy2GxS6Rz5mbHYLp6yk9tZT3qYwTUaM130_assertion type Assertion NP871793.RAIk9I_72ZjG1xoy2GxS6Rz5mbHYLp6yk9tZT3qYwTUaM130_head.
- NP871793.RAIk9I_72ZjG1xoy2GxS6Rz5mbHYLp6yk9tZT3qYwTUaM130_assertion description "[When patients are stratified according to the maximum percentage of E2F3-positive nuclei identified within their prostate cancers (up to 20, 21-40%, etc.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP871793.RAIk9I_72ZjG1xoy2GxS6Rz5mbHYLp6yk9tZT3qYwTUaM130_provenance.
- NP871793.RAIk9I_72ZjG1xoy2GxS6Rz5mbHYLp6yk9tZT3qYwTUaM130_assertion evidence source_evidence_literature NP871793.RAIk9I_72ZjG1xoy2GxS6Rz5mbHYLp6yk9tZT3qYwTUaM130_provenance.
- NP871793.RAIk9I_72ZjG1xoy2GxS6Rz5mbHYLp6yk9tZT3qYwTUaM130_assertion SIO_000772 15184867 NP871793.RAIk9I_72ZjG1xoy2GxS6Rz5mbHYLp6yk9tZT3qYwTUaM130_provenance.
- NP871793.RAIk9I_72ZjG1xoy2GxS6Rz5mbHYLp6yk9tZT3qYwTUaM130_assertion wasDerivedFrom befree-20140225 NP871793.RAIk9I_72ZjG1xoy2GxS6Rz5mbHYLp6yk9tZT3qYwTUaM130_provenance.
- NP871793.RAIk9I_72ZjG1xoy2GxS6Rz5mbHYLp6yk9tZT3qYwTUaM130_assertion wasGeneratedBy ECO_0000203 NP871793.RAIk9I_72ZjG1xoy2GxS6Rz5mbHYLp6yk9tZT3qYwTUaM130_provenance.